236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The Netherlands, 1–3 June 2018

Wong, S. C. , Straub, V., Ward, L. M., Quinlivan, R. and 236th ENMC workshop participants, (2019) 236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The Netherlands, 1–3 June 2018. Neuromuscular Disorders, 29(3), pp. 251-259. (doi: 10.1016/j.nmd.2019.01.002) (PMID:30803852)

Full text not currently available from Enlighten.

Abstract

On 1–3 June 2018, the 236th European Neuromuscular Centre workshop was held in Hoofddorp, The Netherlands, to discuss the issue of bone protective therapies in Duchenne muscular dystrophy (DMD), in particular, the feasibility of developing clinical trials. Twenty-six delegates, that included 19 experts in the neuromuscular and bone clinical and research fields, three representatives from patient organizations, two adults with DMD and two representatives from industry, attended this workshop.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Wong, Dr Jarod
Authors: Wong, S. C., Straub, V., Ward, L. M., Quinlivan, R., and 236th ENMC workshop participants,
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Neuromuscular Disorders
Publisher:Elsevier
ISSN:0960-8966
ISSN (Online):1873-2364
Published Online:11 January 2019

University Staff: Request a correction | Enlighten Editors: Update this record